Focused Alpha’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$866K Sell
3,271
-55
-2% -$14.5K 0.22% 90
2026
Q2
$845K Buy
3,326
+543
+20% +$127K 0.22% 94
2026
Q1
$680K Buy
2,783
+24
+0.9% +$5.59K 0.21% 101
2025
Q4
$571K Buy
+2,759
New +$546K 0.17% 124

Other funds holding JNJ

Focused Alpha's JNJ Position: Q3 2026 in Review

Focused Alpha reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q3 2026, selling an estimated $14.5K and leaving 3,271 shares worth $866K. The position accounts for 0.22% of the portfolio, ranked #90.

Focused Alpha first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Focused Alpha held 3,271 shares of Johnson & Johnson worth $866K as of Q3 2026.
  • Focused Alpha sold 55 Johnson & Johnson shares in Q3 2026, an estimated $14.5K.
  • Johnson & Johnson made up 0.22% of Focused Alpha's portfolio in Q3 2026, its #90 holding.
  • Focused Alpha first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.